| IELSG54 | Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma |
| Samples required | minimum 100 |
| Investigator responsible(s) | L. Arcaini and D. Rossi |
| Objective(s) | Elucidate molecular features of t-SMZL. |
| Lay summary | Transformation of SMZL (t-SMZL) is associated with poor survival and no specific treatment is currently recommended. The genetics of t-SMZL remain poorly understood, and few studies have specifically investigated this aggressive form of the disease. The previous study IELSG46 revealed the genetic diversity of SMZL, providing the first molecular classification and valuable insights into treatment approaches. Building on these findings, the IELSG54 study aims to understand the genetics, tumor environment and clinical outcomes of t-SMZL. Its objectives include identifying molecular subtypes, uncovering critical pathways, and advancing personalized treatment strategies. |
| DPIA | Impact Assessment on Data Processing |